Inogen Inc at JPMorgan Healthcare Conference Transcript
Welcome, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. Really happy to introduce our next presentation from Inogen, going to bring up Nabil Shabshab, the CEO, and then we'll do some Q&A after. Nabil?
Thank you, Robbie, and thank you for having us here. Welcome, guys. So I'm going to maybe start with those who don't know Inogen that well with a very high-level description.
So we're a global med tech company that is focused on respiratory care, but deep into the oxygen therapy -- long-term oxygen therapy market for chronic respiratory conditions, COPD and beyond that.
As a company, we take our purpose, our true note very seriously, which is improving the lives through respiratory care. It's the globe that hosts the organization together, everybody wakes up every day with a very discerned focus on serving patients much better than the day before. And that's what drives us every day.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |